Registered Trials

• NCT04805125

  Phase 3

  Switzerland

  Total Enrollment: 380

  Official Trial Registration:

  • NCT04805125(Opens in new tab/window)

• NCT04470427

  Phase 3

  United States of America

  Total Enrollment: 30,420

  Official Trial Registration:

  • NCT04470427(Opens in new tab/window)

• NCT04811664

  Phase 3

  United States of America

  Total Enrollment: 37,500

  Official Trial Registration:

  • NCT04811664(Opens in new tab/window)

• NCT04806113

  Phase 3

  Canada

  Total Enrollment: 220

  Official Trial Registration:

  • NCT04806113(Opens in new tab/window)

• NCT04860297

  Phase 3

  United States of America

  Total Enrollment: 240

  Official Trial Registration:

  • NCT04860297(Opens in new tab/window)

• NCT05048940

  Phase 3

  Spain

  Total Enrollment: 386

  Official Trial Registration:

  • NCT05048940(Opens in new tab/window)

• NCT04649151

  Phase 2/3

  United States of America

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04649151(Opens in new tab/window)

• NCT04796896

  Phase 2/3

  United States of America

  Total Enrollment: 6,750

  Official Trial Registration:

  • NCT04796896(Opens in new tab/window)

• NCT05022329

  Phase 2/3

  Canada

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05022329(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• EUCTR2021-002348-57

  Phase 2

  Austria

  Total Enrollment: 60

  Official Trial Registration:

  • EUCTR2021-002348-57(Opens in new tab/window)

• NCT04894435

  Phase 2

  Canada

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT04894435(Opens in new tab/window)

• NCT04761822

  Phase 2

  United States of America

  Total Enrollment: 3,400

  Official Trial Registration:

  • NCT04761822(Opens in new tab/window)

• NCT04405076

  Phase 2

  United States of America

  Total Enrollment: 660

  Official Trial Registration:

  • NCT04405076(Opens in new tab/window)

• NCT04748471

  Phase 2

  Total Enrollment: 180

  Official Trial Registration:

  • NCT04748471(Opens in new tab/window)

• NCT04847050

  Phase 2

  United States of America

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04847050(Opens in new tab/window)

• NCT04930770

  Phase 2

  Total Enrollment: 80

  Official Trial Registration:

  • NCT04930770(Opens in new tab/window)

• NCT04969263

  Phase 2

  United States of America

  Total Enrollment: 200

  Official Trial Registration:

  • NCT04969263(Opens in new tab/window)

• NCT04988048

  Phase 2

  Argentina

  Total Enrollment: 1,760

  Official Trial Registration:

  • NCT04988048(Opens in new tab/window)

• NL9275

  Phase 1/2

  Netherlands

  Total Enrollment: 150

  Official Trial Registration:

  • NL9275(Opens in new tab/window)

• NCT04889209

  Phase 1/2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT04889209(Opens in new tab/window)

• NCT04813796

  Phase 1

  United States of America

  Total Enrollment: 125

  Official Trial Registration:

  • NCT04813796(Opens in new tab/window)

• NCT04785144

  Phase 1

  United States of America

  Total Enrollment: 210

  Official Trial Registration:

  • NCT04785144(Opens in new tab/window)

• NCT04839315

  Phase 1

  United States of America

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04839315(Opens in new tab/window)

• NCT04283461

  Phase 1

  United States of America

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04283461(Opens in new tab/window)